SecBot SecBot
6-K ·Filed Nov 12, 2026

NVS

NOVARTIS AG
NEUTRAL
Impact 3/10
Horizonweeks Processed4d 7h ago SEC0001104659-26-126289
Notable filing: 6-K
Actionable Insight • Neutral

Monitor Novartis's upcoming quarterly filings for use of proceeds and any change in leverage ratios. The $5.5B issuance is sizable but modest relative to a $311.5B market cap and the company's existing debt profile.

DirectionNeutral
Confidencehigh
Horizonweeks

How the stock moved after the report

NEUTRAL VIEWSTOCK BELOW ENTRY AT T+1
Entry
$160.50
T+0 close · Nov 12, 2026 · via day close
Latest settled
−0.19%
T+1 · $160.20
Vs SPY
+1.72%
α at T+1
Next horizon
T+5
in 3d
  1. T+0 · Nov 13 $160.50entry
  2. T+1 · 17h ago −0.19%α +1.72% · $160.20
  3. T+5 · in 3d Pending
  4. T+20 · in 27d Pending
  5. T+60 · in 3mo Pending

Price Chart

Loading chart...

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

Novartis AG, through its subsidiary Novartis Capital Corporation, issued $5.5 billion aggregate principal amount of senior unsecured notes across four tranches (2029, 2032, 2034, 2037), fully guaranteed by Novartis AG. The offering is a routine debt capital markets transaction by a highly rated pharmaceutical company, increasing total debt outstanding by $5.5B at fixed coupons ranging from 4.900% to 5.500%.

Key Facts

  • Novartis Capital Corporation issued $500M of 4.900% Notes due 2029, $1.5B of 5.200% Notes due 2032, $1.75B of 5.300% Notes due 2034, and $1.75B of 5.500% Notes due 2037
  • Total aggregate principal amount is $5.5 billion
  • Notes are fully and unconditionally guaranteed by Novartis AG
  • Anticipated ratings: Aa3 by Moody's, AA- by S&P Global Ratings
  • Settlement date: November 12, 2026 (T+2)
  • Proceeds are for general corporate purposes (per standard underwriting agreement language)

Financial Impact

$5.5 billion in new senior unsecured debt issued at fixed rates of 4.900%-5.500%

debtinterest expense

Risk Factors

  • Increased leverage and interest expense from $5.5B in new debt
  • Refinancing risk at maturity for the four tranches (2029-2037)

Market Snapshot

Exchange
NYSE
Sector
Pharmaceutical Preparations
Analyst Consensus
44% bullish (34 analysts)

Investment Themes

Documents Analyzed

This report is based on 6 SEC documents filed with EDGAR.

DocumentAccession Number
6-K Filing (Primary)0001104659-26-126289
Document: tm2629242d6_ex4-1.htm0001104659-26-126289
Document: tm2629242d6_ex4-4.htm0001104659-26-126289
Document: tm2629242d6_ex4-3.htm0001104659-26-126289
Document: tm2629242d6_ex4-2.htm0001104659-26-126289
Earnings Context (Synthetic; results releases only)0001104659-26-126289

Track record

16 reports on NVS

Performance horizon

4 of 6 bullish or bearish reports moved the stock their way by T+1. Best: +6.86% at T+60 after the Jul 1, 2026 report. 5 of 6 went positive at some point.

Filters
  1. Nov 12, 20264d ago 6-K Neutral 3/10 Viewing Entry $160.50 to $160.20 Now $160.20 −0.19% ▼ −0.19% +1.72% vs SPY
  2. Nov 10, 20267d ago PTAB Trial Neutral 3/10 Entry $163.26 to $160.32 Now $160.20 −1.87% ▼ −1.80% −3.12% vs SPY
  3. Oct 28, 202619d ago 144 Neutral 2/10 Entry $156.08 to $161.10 Now $160.20 +2.64% ▲ +3.22% +3.60% vs SPY
  4. Oct 27, 202620d ago 6-K Mixed 6/10 Entry $156.86 to $156.08 Now $160.20 +2.13% ▼ −0.50% −0.84% vs SPY
  5. Oct 15, 20264w ago Court Ruling Neutral 2/10 Entry $150.62 to $150.20 Now $160.20 +6.36% ▼ −0.28% −0.70% vs SPY
  6. Oct 13, 20265w ago Court Ruling Bearish 5/10 Entry $146.88 to $150.38 Now $160.20 −9.07% ▼ −2.38% −2.10% vs SPY
  7. Sep 22, 20267w ago Institutional Cluster Mixed 4/10 Entry $141.28 to $142.71 Now $160.20 +13.39% ▲ +1.01% +1.73% vs SPY
  8. Sep 4, 202610w ago 6-K Bearish 6/10 Entry $137.70 to $137.48 Now $160.20 −16.34% ▲ +0.16% −0.30% vs SPY
  9. Sep 1, 202610w ago 6-K Bullish 7/10 Entry $161.25 to $162.46 Now $160.20 −0.65% ▲ +0.75% +0.31% vs SPY
  10. Aug 4, 202615w ago Court Ruling Neutral 2/10 Entry $154.44 to $154.21 Now $160.20 +3.73% ▼ −0.15% +0.01% vs SPY
Showing 10 of 16

US Market Status

Market Closed · Opens in 9h 4m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Nov 12, 2026